Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.73
-0.09-4.95%
At close: Jun 5, 5:00 PM EST
$1.76
-0.06-3.30%
Pre-Market: 8:14 AM EST
iBio Inc Analyst Ratings
IBIONASDAQ
iBio Analyst Ratings and Price Targets | NASDAQ:IBIO | Benzinga
iBio Inc has a consensus price target of $4.8 based on the ratings of 7 analysts. The high is $7 issued by Jones Trading on March 3, 2026. The low is $2 issued by Leerink Partners on October 17, 2025. The 3 most-recent analyst ratings were released by Raymond James, Chardan Capital, and Chardan Capital on June 8, 2026, April 9, 2026, and March 18, 2026, respectively. With an average price target of $5 between Raymond James, Chardan Capital, and Chardan Capital, there's an implied 184.09% upside for iBio Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Raymond James
Chardan Capital
Jones Trading
Oppenheimer
Leerink Partners
1calculated from analyst ratings
Analyst Ratings for iBio
Loading calendar...
FAQ
What is the target price for iBio (IBIO) stock?
The latest price target for iBio (NASDAQ:IBIO) was reported by Raymond James on June 8, 2026. The analyst firm set a price target for $5.00 expecting IBIO to rise to within 12 months (a possible 184.09% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for iBio (IBIO)?
The latest analyst rating for iBio (NASDAQ:IBIO) was provided by Raymond James, and iBio initiated their outperform rating.
When was the last upgrade for iBio (IBIO)?
There is no last upgrade for iBio
When was the last downgrade for iBio (IBIO)?
There is no last downgrade for iBio.
When is the next analyst rating going to be posted or updated for iBio (IBIO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of iBio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for iBio was filed on June 8, 2026 so you should expect the next rating to be made available sometime around June 8, 2027.
Is the Analyst Rating iBio (IBIO) correct?
While ratings are subjective and will change, the latest iBio (IBIO) rating was a initiated with a price target of $0.00 to $5.00. The current price iBio (IBIO) is trading at is $1.76, which is within the analyst’s predicted range.
